Ultragenyx Pharmaceutical (RARE) Other Working Capital Changes (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Other Working Capital Changes of $9.0 million for Q1 2026, down 47.06% year-over-year from $17.0 million in Q1 2025, and up 228.47% on a QoQ basis from $2.7 million in Q4 2025.
Ultragenyx Pharmaceutical (RARE) has 14 years of Other Working Capital Changes data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Other Working Capital Changes fell 47.06% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 82.69% YoY) and the FY2025 annual result came in at $10.0 million, up 183.33% from the prior year.
- Other Working Capital Changes improved to $9.0 million in Q1 2026 per RARE's latest filing, from $2.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $17.0 million in Q1 2025 and bottomed at -$12.7 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is $165000.0 (2025), against an average of -$694000.0.
- The widest annual swing landed in 2022, when Other Working Capital Changes jumped 1062.45%; it then sank 1362.62% in 2024.
- Tracing RARE's Other Working Capital Changes over 5 years: stood at -$3.2 million in 2022, then soared by 148.89% to $1.6 million in 2023, then plunged by 83.02% to $269000.0 in 2024, then surged by 918.59% to $2.7 million in 2025, then soared by 228.47% to $9.0 million in 2026.
- Per Business Quant, the three latest RARE Other Working Capital Changes figures stand at $9.0 million (Q1 2026), $2.7 million (Q4 2025), and -$9.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | -9.91 Mn |
| Sep 30, 2025 | -9.91 Mn |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 17.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 269,000.00 |
| Dec 31, 2024 | 269,000.00 |
| Sep 30, 2024 | -12.72 Mn |
| Sep 30, 2024 | -12.72 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | -6.55 Mn |
| Mar 31, 2024 | -6.55 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | -4.99 Mn |
| Sep 30, 2023 | -4.99 Mn |
| Jun 30, 2023 | -12.11 Mn |
| Jun 30, 2023 | -12.11 Mn |
| Mar 31, 2023 | 519,000.00 |
| Mar 31, 2023 | 519,000.00 |
| Dec 31, 2022 | -3.24 Mn |
| Dec 31, 2022 | -3.24 Mn |
| Sep 30, 2022 | -7.35 Mn |
| Sep 30, 2022 | -7.35 Mn |
| Jun 30, 2022 | 15.92 Mn |
| Jun 30, 2022 | 15.92 Mn |
| Mar 31, 2022 | -9.13 Mn |
| Mar 31, 2022 | -9.13 Mn |
| Dec 31, 2021 | 22.53 Mn |
| Dec 31, 2021 | 22.53 Mn |
| Sep 30, 2021 | -2.02 Mn |
| Sep 30, 2021 | -2.02 Mn |
| Jun 30, 2021 | -1.65 Mn |
| Jun 30, 2021 | -1.65 Mn |
| Mar 31, 2021 | 10.66 Mn |
| Mar 31, 2021 | 10.66 Mn |
| Dec 31, 2020 | -15.21 Mn |
| Dec 31, 2020 | -15.21 Mn |
| Sep 30, 2020 | 6.33 Mn |
| Sep 30, 2020 | 6.33 Mn |
| Jun 30, 2020 | -8.96 Mn |
| Jun 30, 2020 | -8.96 Mn |
| Mar 31, 2020 | 15.10 Mn |
| Mar 31, 2020 | 15.10 Mn |
| Dec 31, 2019 | 2.34 Mn |
| Dec 31, 2019 | 2.34 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 2.85 Mn |
| Jun 30, 2019 | 2.85 Mn |
| Mar 31, 2019 | 1.41 Mn |
| Mar 31, 2019 | 1.41 Mn |
| Dec 31, 2018 | -6.10 Mn |
| Dec 31, 2018 | -6.10 Mn |
| Sep 30, 2018 | 12.84 Mn |
| Sep 30, 2018 | 12.84 Mn |
| Jun 30, 2018 | 2.29 Mn |
| Jun 30, 2018 | 2.29 Mn |
| Mar 31, 2018 | 5.25 Mn |
| Mar 31, 2018 | 5.25 Mn |
| Dec 31, 2017 | -2.35 Mn |
| Dec 31, 2017 | -2.35 Mn |
| Sep 30, 2017 | -291,000.00 |
| Sep 30, 2017 | -291,000.00 |
| Jun 30, 2017 | 461,000.00 |
| Jun 30, 2017 | 461,000.00 |
| Mar 31, 2017 | -930,000.00 |
| Mar 31, 2017 | -930,000.00 |
| Dec 31, 2016 | 1.31 Mn |
| Dec 31, 2016 | 1.31 Mn |
| Sep 30, 2016 | 1.28 Mn |
| Sep 30, 2016 | 1.28 Mn |
| Jun 30, 2016 | 526,000.00 |
| Jun 30, 2016 | 526,000.00 |
| Mar 31, 2016 | 4.03 Mn |
| Mar 31, 2016 | 4.03 Mn |
| Dec 31, 2015 | 736,000.00 |
| Dec 31, 2015 | 736,000.00 |
| Sep 30, 2015 | 2.89 Mn |
| Sep 30, 2015 | 2.89 Mn |
| Jun 30, 2015 | 2.55 Mn |
| Jun 30, 2015 | 2.55 Mn |
| Mar 31, 2015 | 948,000.00 |
| Mar 31, 2015 | 948,000.00 |
| Dec 31, 2014 | 382,000.00 |
| Dec 31, 2014 | 382,000.00 |
| Sep 30, 2014 | 602,000.00 |
| Sep 30, 2014 | 602,000.00 |
| Jun 30, 2014 | 706,000.00 |
| Jun 30, 2014 | 706,000.00 |
| Mar 31, 2014 | 2.39 Mn |
| Mar 31, 2014 | 2.39 Mn |
| Dec 31, 2013 | 206,000.00 |
| Dec 31, 2013 | 206,000.00 |
| Sep 30, 2013 | 99,000.00 |
| Sep 30, 2013 | 99,000.00 |
| Jun 30, 2013 | 512,000.00 |
| Jun 30, 2013 | 512,000.00 |
| Mar 31, 2013 | 776,000.00 |
| Mar 31, 2013 | 776,000.00 |